News
Rankings of most common cancers to shift over next 20 years
“It’s time to shift focus to some of the less commonly diagnosed cancers with the lowest survival rates, like pancreatic and liver cancer.”
News
Starting April 5, patients can read your notes: 5 things to consider
Health care groups must provide patients with immediate electronic access to their doctor’s clinical notes.
News
Pembrolizumab SCLC indication withdrawn in U.S.
The small cell lung cancer indication had been granted an accelerated approval, but a subsequent confirmatory study showed no survival benefit.
News
Bladder cancer indication withdrawn for durvalumab
AstraZeneca has withdrawn durvalumab’s indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit...
News
Case study: Maternal cervical cancer linked to neonate lung cancer
Researchers report two cases of lung cancer transmitted via the birth canal from mothers with cervical cancer.
News
‘Contrary’ to wide belief, abscopal effect is rare in cancer
The abscopal effect, whereby tumors are reduced or eliminated even though they are situated outside the radiation field, was first described in...
News
FDA OKs first oral hormone therapy for advanced prostate cancer
Relugolix is an oral form of androgen deprivation therapy.
News
CTCs predict overall survival in metastatic breast cancer
New data seem to support using circulating tumor cells to assess treatment efficacy in practice, but an expert has doubts.
News
SABCS 2020: What’s hot, including a major chemotherapy trial
The world’s largest breast cancer meeting starts on Dec. 8.
News
HHS extends deadline for patient access to your clinical notes
Government cites the COVID-19 pandemic as the reason for the delay.
News
Patients can read your clinical notes starting Nov. 2
“Open notes” mandates immediate patient access to inpatient and outpatient notes and testing and imaging results.